Connection
Jessica Christenson to Trastuzumab
This is a "connection" page, showing publications Jessica Christenson has written about Trastuzumab.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.126 |
|
|
|
-
Christenson JL, Denny EC, Kane SE. t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib. Oncotarget. 2015 Oct 20; 6(32):33134-45.
Score: 0.126